BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+9.77%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$713M
AUM Growth
+$713M
(-19%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-30.64%
Top 10 Holdings %
Top 10 Hldgs %
55.41%
Holding
67
New
4
Increased
8
Reduced
17
Closed
16
Top Buys
| 1 |
Heron Therapeutics
HRTX
|
$15.7M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$6.58M |
| 3 |
DexCom
DXCM
|
$4.18M |
| 4 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$3.9M |
| 5 |
CORI
Corium International, Inc.
CORI
|
$3.63M |
Top Sells
| 1 |
PGNX
Progenics Pharmaceuticals Inc
PGNX
|
$65.6M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$23.5M |
| 3 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$21.7M |
| 4 |
GNMX
Aevi Genomic Medicine, Inc.
GNMX
|
$17.5M |
| 5 |
ATRS
Antares Pharma, Inc.
ATRS
|
$15.1M |
Sector Composition
| 1 | Healthcare | 89.39% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACGN
26
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $9.52M | 1.15% |
3,852,945
-574,800
| -13% | -$1.42M |
|
|
AMRN
27
Amarin Corp
AMRN
$311M
| $9.07M | 1.1% |
2,833,649
| – | – |
|
28
DURECT Corp
DRRX
$59.6M
| $8.93M | 1.08% |
8,506,229
| – | – |
|
|
SPNE
29
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $8.63M | 1.05% |
1,099,807
-200
| -0% | -$1.57K |
|
|
BCR
30
DELISTED
CR Bard Inc.
BCR
| $6.79M | 0.82% |
27,300
-12,900
| -32% | -$3.21M |
|
31
ADMA Biologics
ADMA
$4.1B
| $5.02M | 0.61% |
1,028,672
-84,621
| -8% | -$413K |
|
32
Cidara Therapeutics
CDTX
$1.66B
| $4.39M | 0.53% |
562,875
| – | – |
|
|
NVET
33
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
| $4.39M | 0.53% |
1,127,200
| – | – |
|
|
PRTK
34
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $4.31M | 0.52% |
223,862
-562,272
| -72% | -$10.8M |
|
35
MediWound
MDWD
$182M
| $4.18M | 0.51% |
633,102
| – | – |
|
|
36
DexCom
DXCM
$29.5B
| $4.18M | 0.51% |
+49,300
| New | +$4.18M |
|
37
SCYNEXIS
SCYX
$34.9M
| $4.08M | 0.49% |
1,477,273
| – | – |
|
|
JUNO
38
DELISTED
Juno Therapeutics, Inc.
JUNO
| $3.9M | 0.47% |
+175,700
| New | +$3.9M |
|
|
CFRX
39
DELISTED
ContraFect Corporation
CFRX
| $2.57M | 0.31% |
1,429,109
| – | – |
|
|
VXRT
40
DELISTED
Vaxart
VXRT
| $2.07M | 0.25% |
3,179,226
-307,485
| -9% | -$200K |
|
41
Arcturus Therapeutics
ARCT
$462M
| $1.39M | 0.17% |
1,216,643
-840,463
| -41% | -$958K |
|
|
CGNT
42
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.36M | 0.16% |
753,773
| – | – |
|
|
AVGR
43
DELISTED
Avinger, Inc. Common Stock
AVGR
| $950K | 0.12% |
+500,000
| New | +$950K |
|
|
WINT
44
DELISTED
Windtree Therapeutics Inc
WINT
| $887K | 0.11% |
777,797
| – | – |
|
|
DXTR
45
DELISTED
Dextera Surgical Inc.
DXTR
| $635K | 0.08% |
599,440
-236,927
| -28% | -$251K |
|
46
Strata Skin Sciences
SSKN
$11.8M
| $582K | 0.07% |
961,422
| – | – |
|
47
Alphatec Holdings
ATEC
$2.35B
| $527K | 0.06% |
+226,006
| New | +$527K |
|
48
Glaukos
GKOS
$5.5B
| – | – |
-141,300
| Closed | -$4.85M |
|
49
Medtronic
MDT
$120B
| – | – |
-75,000
| Closed | -$5.34M |
|
50
Pacira BioSciences
PCRX
$1.2B
| – | – |
-150,680
| Closed | -$4.87M |
|